what are the clinical trials for retatrutide Retatrutide, Eli Lilly's next generation of weight loss injections, showed dramatic results in trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli AllWell - Everyone keeps asking

42 , D1001D1006 (2014)

Biological Activity 5 (GSH-d 5

I also feel scared to get the second shot and that nobody is reporting the type of reactions you and I experienced

Soare A, Gyrfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, et al

Professional medical supervision remains essential for safety and efficacy during any treatment plan

Long-term considerations Maintenance dosing After reaching goal weight: Some continue at therapeutic dose indefinitely Others may reduce to lower maintenance dose (4-8 mg) Weight regain is common if medication is stopped Long-term studies are ongoing Duration of treatment Based on clinical trial data: Weight loss continues for at least 48-68 weeks Plateau may not occur even at 48 weeks Long-term (multi-year) data not yet available Treatment may be indefinite for weight maintenance Monitoring recommendations Regular check-ins should include: Weight and body composition Blood pressure and heart rate Blood glucose and HbA1c Lipid panel Liver and kidney function Review of symptoms and side effects Frequently asked questions What is the starting dose for retatrutide